Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
32.37
-1.07
(-3.20%)
At close: 12:10:05 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-28,086
-31,413
-176,170
-295,634
-214,507
Investing Cash Flow
-61,579
-50,651
-20,013
-332
-24,510
Financing Cash Flow
134,598
72,705
-391
41,419
679,827
End Cash Position
197,117
94,218
103,577
300,151
554,698
Interest Paid Supplemental Data
16,890
8,771
5,445
3,466
4,501
Capital Expenditure
--
--
-14
-401
-357
Issuance of Capital Stock
-1
46,296
--
2,219
679,680
Issuance of Debt
244,815
25,000
--
70,000
--
Repayment of Debt
-107,553
--
-975
-30,000
--
Free Cash Flow
-28,110
-31,413
-176,184
-296,035
-214,864
12/31/2020 - 10/23/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ICY.HA Incyte Corp
64.94
-3.79%
25K.MU Karyopharm Therapeutics Inc
0.5920
0.00%
ICY.DU Incyte Corp
65.22
-3.72%
ICY.F Incyte Corporation
66.78
-5.06%
GNPX Genprex, Inc.
0.3350
-3.74%
ONCY Oncolytics Biotech Inc.
0.6500
-1.96%
INCY Incyte Corporation
69.68
-0.83%
SYRS Syros Pharmaceuticals, Inc.
0.0850
+3.66%
DRUG Bright Minds Biosciences Inc.
32.23
-7.70%
HUMA Humacyte, Inc.
3.2000
+4.75%